Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision was updated to v3.5.4, signaling a new release of the page; the visible study details appear unchanged.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision/version indicator was updated (from v3.5.2 to v3.5.3). This reflects a minor versioning change rather than an update to the study details.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3; no substantive study details or eligibility criteria appear to be affected.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.1%

- Check103 days agoChange DetectedThe update adds a new site revision label (v3.4.2) and removes the previous funding-status notice and earlier revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.